Evidence map›Paper›PMID 30705675›Full record

ArticleFrontiers in immunology2018

The Autoimmune-Associated Single Nucleotide Polymorphism Within

Kevin Budding, Jessica van Setten, Eduard A van de Graaf, Oliver A van Rossum, Tineke Kardol-Hoefnagel, Johanna M Kwakkel-van Erp, Erik-Jan D Oudijk, C Erik Hack, Henderikus G Otten

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kevin BuddingLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Jessica van SettenDepartment of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.
Eduard A van de GraafDepartment of Respiratory Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
Oliver A van RossumLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Tineke Kardol-HoefnagelLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Johanna M Kwakkel-van ErpDepartment of Respiratory Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
Erik-Jan D OudijkCenter of Interstitial Lung Diseases, St. Antonius Hospital, Nieuwegein, Netherlands.
C Erik HackLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Henderikus G OttenLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
University Medical Center Utrecht · NLSt. Antonius Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive chronic lung allograft dysfunction (BOS) is the major limiting factor for lung transplantation (LTx) outcome.

Indexed as

AdultAllograftsAutoimmunityBronchiolitis ObliteransDisease-Free SurvivalFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGraft RejectionHeterozygoteHumansKaplan-Meier EstimateLungLung TransplantationMaleMiddle AgedProtein Tyrosine Phosphatase, Non-Receptor Type 22PTPN22 protein, humanbronchiolitis obliterans syndromechronic lung allograft dysfunctionlung transplantationPTPN22transplantation genetics

Identifiers

PMID30705675
PMCPMC6344400
OpenAlexW2910269351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.